Police in northern Switzerland say several people have been detained and a criminal case opened in connection with the suspected death of a person in a new “suicide capsule”.
The “Sarco” capsule, which has never been used before, is designed to allow a person inside to push a button that injects nitrogen gas into the sealed chamber. The person is then supposed to fall asleep and die by suffocation in a few minutes.
Prosecutors in Schaffhausen canton were informed by a law firm that an assisted suicide involving use of the Sarco capsule had taken place on Monday near a forest cabin in Merishausen, police said in a statement.
Police added that “several people” were taken into custody and prosecutors had opened an investigation on suspicion of incitement and accessory to suicide.
The Dutch newspaper Volkskrant reported on Tuesday that police had detained one of its photographers who wanted to take pictures of the use of the capsule. It said Schaffhausen police indicated the photographer was being held at a police station but gave no further explanation.
The newspaper declined to comment further when contacted by Associated Press.
Exit International, an assisted suicide group based in the Netherlands, has said it is behind the 3D-printed device that cost more than $1m to develop.
Swiss law allows assisted suicide as long as the person takes his or her life with no “external assistance” and those who help the person die do not do so for “any self-serving motive”, according to a government website.
Dr Philip Nitschke, an Australian doctor who was behind Exit International, has told AP that his organisation had received advice from lawyers in Switzerland that use of the Sarco would be legal in the country.
In July, the Swiss newspaper Blick reported that Peter Sticher, a state prosecutor in Schaffhausen, wrote to Exit International’s lawyers saying that any operator of the capsule could face criminal proceedings if it was used there – and any conviction could bring up to five years in prison.
Prosecutors in other Swiss regions have also indicated that use of the capsule could lead to prosecution.
Over the summer, a 54-year-old woman from the US with multiple health ailments had planned to be the first person to use the device, but those plans were abandoned.